Michael Carulli - 05 Mar 2026 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: Chief Financial Officer
Signature: /s/ Robert Ticktin, by power ot attorney
Issuer symbol: PMVP
Transactions as of: 05 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2026, 16:41:27 UTC
Previous filing: 03 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Carulli Michael	Chief Financial Officer	C/O PMV PHARMACEUTICALS, INC., 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON	/s/ Robert Ticktin, by power ot attorney	09 Mar 2026	0002006668

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PMVP	Common Stock						73,848	05 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMVP	Employee Stock Option (right to buy)	Award		+240,000		$0.000000^*	240,000	05 Mar 2026	Common Stock	240,000	$1.53	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 13,702 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025.
F2	Shares subject to the option vest in 48 equal monthly installments beginning on April 5, 2026.